Comparing two diabetes pills for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study compares two medications, trelagliptin and sitagliptin, to see which works better for people with type 2 diabetes. It might be an option if you are already taking metformin but your blood sugar levels are still not under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You are already taking metformin and making lifestyle changes, but your HbA1c (a blood sugar measure) is still above 6.5% and below 10%
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have severe kidney, heart, or pancreatic problems
- You have not had an allergic reaction to this class of diabetes drugs before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a sodium-glucose cotransporter-2 inhibitor (SGLT2i), a thiazolidinedione (TZD), or a combination of both to your current DPP4 inhibitor-based treatment can improve blood sugar control in type 2 diabetes. It aims to find the best add-on option for people who need extra help managing their diabetes.
This study compares two different two-drug combinations for people recently diagnosed with type 2 diabetes. It aims to find which combination works better to control blood sugar and improve overall health.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This trial compares two different combinations of diabetes pills (metformin plus empagliflozin with either sitagliptin or linagliptin) in people with type 2 diabetes who have not been treated before. It aims to see which combination works better and is safer for controlling blood sugar.
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
This study tests a new medication called TriGlytza-01 against the standard diabetes drug metformin. It is for adults with type 2 diabetes who are overweight or obese and whose blood sugar is not well controlled with metformin alone.
Hear when a new Glycemic Control for Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.